MARATTO

article · EClinicalMedicine

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial

2026Open accessUniversity of Zambia

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

This project is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP2) program supported by the European Union (RIA2017MC-2013).

Research topics

  • HIV/AIDS drug development and treatment
  • Cytomegalovirus and herpesvirus research
  • Pneumocystis jirovecii pneumonia detection and treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1016/j.eclinm.2026.103899

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.